Daniel Springer
UiPathAbout Daniel D. Springer
Daniel D. Springer (age 61) is an independent director of UiPath (PATH) since March 2021, serving on the Audit and Compensation Committees; he is currently CEO of Ironclad (since April 2025) and formerly CEO/President of DocuSign (2017–2022) . He holds a B.A. from Occidental College and an MBA from Harvard University, and is considered independent under NYSE standards; the board reported all directors met at least 75% attendance in FY2025 and attended the 2024 annual meeting .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| DocuSign, Inc. | Chief Executive Officer & President | Jan 2017 – Jun 2022 | Led scaling of e-signature platform; subsequently served on DocuSign board until Apr 2025 |
| Advent International Corp. | Operating Partner | May 2015 – Jan 2017 | Private equity operating role supporting portfolio execution |
| Responsys, Inc. | Chairman & Chief Executive Officer | Mar 2004 – Mar 2014 | Led marketing software firm through acquisition by Oracle in 2014 |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Ironclad (private) | Chief Executive Officer | Apr 2025 – Present | Contract lifecycle management software; not identified as related party to PATH |
| DocuSign, Inc. | Director | Jan 2017 – Apr 2025 | Public company directorship ended Apr 2025 |
| YuMe Inc. | Director | Oct 2013 – Jul 2017 | Prior public board service |
Board Governance
- Independence: Board determined Springer is independent for NYSE and committee service .
- Committees: Audit Committee member (Chair: Michael Gordon; all members independent; Gordon designated “financial expert”) . Compensation Committee member (Chair: Richard P. Wong; all members independent and “non-employee” under Rule 16b-3) .
- Attendance and engagement: Board met 7 times; Audit 10; Compensation 6; Nominating 4 in FY2025; each director attended ≥75% of aggregate meetings and all directors attended the 2024 Annual Meeting .
- Executive sessions: Non-employee directors met quarterly in executive session; presided by Lead Independent Director Richard P. Wong .
- Related-party oversight: Audit Committee charter includes reviewing related party transactions ; proxy disclosed one related-person transaction (CEO’s brother employment) and no transactions involving Springer .
Fixed Compensation
| Component | FY2025 Amount | Notes |
|---|---|---|
| Fees Earned or Paid in Cash | $60,000 | Consistent with policy: $30,000 board retainer + $15,000 audit committee member + $15,000 compensation committee member |
| Equity (RSU) Grant – Annual | $193,529 grant-date fair value | 17,021 RSUs granted in June 2024 to each serving non-employee director |
| Total FY2025 Director Compensation | $253,529 | Sum of cash and equity |
Performance Compensation
| Award | Grant date | Shares / Units | Fair Value | Vesting / Performance |
|---|---|---|---|---|
| Annual RSU (Director) | Jun 2024 | 17,021 RSUs | $193,529 | Time-based; vests at next annual meeting or first anniversary, contingent on continued service |
| Change-in-control treatment | — | — | — | Director RSUs vest in full upon change in control under the 2021 Plan |
| Performance metrics | — | — | — | Not applicable to director RSUs; awards are time-based (no revenue/TSR hurdles disclosed) |
Other Directorships & Interlocks
| Company | Relationship to PATH | Interlock/Conflict Notes |
|---|---|---|
| DocuSign, Inc. (public) | No disclosed transaction with PATH | Springer served on board until Apr 2025; no related-party transactions disclosed involving Springer |
| Ironclad (private) | Potential ecosystem adjacency (software) | Current CEO role; no PATH-related transactions disclosed; Audit Committee reviews related-party transactions |
| YuMe Inc. (public, prior) | None | Historical board role ended 2017 |
Expertise & Qualifications
- Public company CEO experience (DocuSign), extensive software/cloud management, and sales/marketing expertise; MBA Harvard, BA Occidental .
- Committee experience on Audit and Compensation, contributing finance and governance oversight; Audit Committee deemed members able to understand fundamental financial statements .
Equity Ownership
| Item | Amount |
|---|---|
| Beneficial Ownership – Class A shares | 119,055 shares (<1%) as of Apr 29, 2025 |
| RSUs outstanding (director grants) | 17,021 units as of Jan 31, 2025 |
| Ownership guidelines (directors must hold 5x annual retainer) | Springer in compliance as of Jan 31, 2025; directors (except Somasegar, Yang) met guideline |
| Hedging/Pledging | Prohibited by PATH insider trading policy |
Insider Trading & Section 16(a) Compliance
| Item | Disclosure |
|---|---|
| Section 16(a) reports | Company believes all directors and officers filed timely reports for FY2025 |
| Hedging/short sales/derivatives/margin/pledging | Prohibited under PATH insider trading policy |
Governance Assessment
- Strengths: Independent status; dual committee membership (Audit and Compensation) enhances oversight; attendance thresholds met; executive sessions led by independent LID; no related-party transactions disclosed involving Springer; director equity and ownership guidelines align incentives (5x retainer; compliance) .
- Compensation structure: Cash fees modest and role-based; equity in RSUs with standard time-based vesting; change-in-control full vesting for directors typical but warrants awareness in transaction scenarios .
- Potential watch items: External CEO role at Ironclad increases time demands, but FY2025 attendance standards were met; no evidence of hedging/pledging or related-party exposure .
RED FLAGS: None identified in proxy disclosures (no conflicts/related-party transactions, hedging/pledging prohibited; Section 16(a) compliance affirmed) .